Recent content from Joe Carlson
The medical device maker adjusted its prior-year results to make it easier for investors to understand its performance with the acquisition of Covidien.
The company is expected to talk about its outlook for the year as it announces results Tuesday.
Minnesota’s pioneering medical devices are part of national museum exhibit opening July 1.
The clinical trial for its heart-failure therapy is back on after pause due to deaths.
The city of Minnetonka, listed as a creditor, lent the firm $500,000 in 2013.
Physicians, and some stock analysts, are closely watching the safety profile of tiny novel pacemakers like the Nanostim in ongoing studies. Implants of the device have been halted in Europe after several became dislodged.
Financial performance since acquisition was better than expected.
The aftermath of indictments of Vascular Solutions has many executives seeking extra counsel on marketing maneuvers.
Health insurers are skeptical of a Minnesota firm’s acid-reflux device.
The health plan joins the med-tech start-up space as an anchor tenant.
Dr. Wesley Pederseni mplanted a locally designed mitral heart valve through a small tube in the beating heart of a patient, becoming the first doctor to do so in the United States.
Gertrude P. Ulrich could have moved out of Richfield when her house on Aldrich Avenue and 76th Street was torn down in the name of…
A St. Louis Park company is working with the Mayo Clinic to develop a mobile app to measure a person’s stress level.
Doctors’ financial interests, and potential conflicts, have become public information
The new Open Payments data has injected hard numbers into a debate over whether large checks can lead doctors to use certain products.
Revenue from sales of medical devices to clear plaque from blood vessels jumped 36 percent in the most recent quarter for New Brighton’s Cardiovascular Systems…
Boston Scientific agreed to pay about $119 million to settle lawsuits involving nearly 3,000 women.
FDA said the company has failed to fix problems with the SynchroMed II device.
The therapy is attractive for frail patients because it avoids the need to cut open the chest.
Medtronic PLC is buying a Dutch diabetes clinic and research center, a modest but strategically significant acquisition for the global medical device giant.
Billions in profits at stake as big players seek to prove renal denervation therapy works.
St. Jude shares rose sharply after it reported stronger-than-expected results.
Device from Spinal Modulation, of Belgium, stimulates nerve center to treat chronic pain.
Magnetic rods in patients with severe scoliosis avoid multiple surgeries
Studies show removal of clots with Solitaire device may be more effective than drugs alone.
Medtronic joins crosstown rival St. Jude Medical Inc. in speeding toward full commercial approval from the Food and Drug Administration for U.S. sales.
BioSig Technologies plans to add a dozen employees.
At Abbott, Roseville company’s new mitral device gets its first human patient
EmboMedics’ therapy lacks FDA approval, but a New York firm paid $2 million for rights to it.
The med-tech company was charged with selling spinal surgery devices to the U.S. military that were made in China and Malaysia, in violation of U.S. law.
This follows the earlier failure of their renal denervation trial.
Incontinence-device maker is Cogentix Medical.
UnitedHealth beefs up drug benefits role with Catamaran acquisition.
Vascular Solutions and its defiant CEO are expected to deploy a free-speech defense against conspiracy charges.
Responding to calls for pediatric devices, St. Jude launches clinical trial of a mechanical heart valve for children.
Sophono Inc. makes a hearing device implant that transmits sound through the skin.
It has been on a steady rise since its fall amid a Wells Fargo downgrade, growth concerns.
Local companies tout approvals, products, outcomes in time for cardiologists’ annual meeting.
Company’s stock climbed after the FDA approved a mechanism that will cut some stroke risks.
Boston Scientific, Medtronic and St. Jude are in the competition over a medical technology niche poised to balloon to $4 billion in global sales five years from now.
Study found that 1 in 4 died within a year but many were aged and ill with other ailments.
The valve device is seen as a promising niche for medical technology.
Sunshine Heart said the four deaths don’t appear to be related to the device.
Advanced Circulatory Systems’ device has improved survival rates for heart-attack patients.
Marchers celebrate accomplishments but say there's much to be done toward racial equality.
The company’s $1.65B purchase of Minnetonka business dovetails with current products.
A new device made by St. Jude Medical detects subtle changes in blood pressure, allowing doctors to treat failing hearts before patients end up in the emergency room.
The firm agreed to settle claims for the defibrillator leads, which degraded in as little as four years.
Minnesota doctors remain vigilant in efforts to clean endoscopes and monitor for infectious outbreaks
Summit Medical makes trays to sterilize reusable surgical tools.
The deal puts the device maker in direct competition with Minnetonka’s Uroplasty
Tracking medical devices could eventually spare patients from suffering complications.
Investors applauded its settlement with J&J, but the Twin Cities medical device giant isn’t done with the courts.
The medical device giant posted strong results in its last report before moving to Dublin.
World’s biggest device maker may find more debt reduces flexibility to respond to setbacks, according to a new report.
Thanks to Covidien deal, medical company will benefit from new stent, stroke findings.
The FDA has classified the company recall of mislabeled infusion systems as a Class 1, which means that patients could be harmed.
It’s competing with Medtronic, selling device that is increasingly used instead of stents in vascular surgery.
EV3 will pay $1.25 million to settle allegations of overbilling without admitting wrongdoing.
The company reported a fifth straight quarter of sales growth but faces some big challenges.
Eden Prairie’s Celleration uses ultrasound waves to stimulate wound healing.
The company touts strong sales growth in China despite currency challenges.
Donald Lucker never had formal training in computers, or in business for that matter. But after joining a Minneapolis metal fabrication company as an air…
Shares in the combined company, Medtronic PLC, are expected to begin trading Tuesday.
With the acquisition of Covidien a done deal, Medtronic executives now must show that the union offers more than just tax benefits.
The company is buying a facility in Maple Grove as it fights a criminal case.
The company plans to adopt a currency-hedging program to moderate earnings fluctuations caused by exchange rates.
The landlords of Target’s 130 leased retail stores in Canada are likely to be among the biggest losers in a bankruptcy process started by Target…
Roseville company wins FDA approval for implant that signals brain not to crave food.
The company also said it will begin a $500 million stock buyback program.
Omnis signed agreement with global drugmaker AstraZeneca.
Latest technology developed by a unit of Covidien Inc. lets cancer doctors guide scopes through labyrinthine airways without cutting tissue.
Shareholders approve deal as executives tout jobs and opponents criticize tax hit.
Drug-coated balloons projected to sell well for the Fridley firm amid its Covidien acquisition.
Medtronic and Covidien stock owners will weigh in this week on the much-debated $48 billion merger.
From Around the Web
More from Star Tribune